Fetal exposure to canakinumab: a report of three pregnancies

Fetal exposure to canakinumab: a report of three pregnancies

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical rheumatology 2022-04, Vol.41 (4), p.1261-1263
Hauptverfasser: İlgen, Ufuk, Eyüpoğlu, Şahin, Yayla, Müçteba Enes, Küçükşahin, Orhan
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Humanized - adverse effects
Double-Blind Method
Female
Fetuses
Humans
Interleukin-1beta
Letters of Biomedical and Clinical Research
Medicine
Medicine & Public Health
Pregnancy
Rheumatology
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1263
container_issue 4
container_start_page 1261
container_title Clinical rheumatology
container_volume 41
creator İlgen, Ufuk
Eyüpoğlu, Şahin
Yayla, Müçteba Enes
Küçükşahin, Orhan
description
doi_str_mv 10.1007/s10067-022-06060-y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2619217124</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2619217124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-5f561aaa3c59c3aa9e8bd650e8d4b0a148f73179808118ea917d9ad4458d88f73</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMoun78AQ9S8OKlOtM0TSJeRFwVBC96DrPtdF3dbWvSgvvvzbp-gAcJTA7zzDvDI8QhwikC6LMQa6FTyLIUivjS5YYYYS7z1NrcbooRaA2pRGt2xG4ILwCQGYvbYkcqQKOMHImLMfc0T_i9a8PgOenbpKSGXmfNsKDJeUKJ5671fdLWSf_smZPO87Shppxx2BdbNc0DH3z9e-JpfP14dZveP9zcXV3ep6XUqk9VrQokIlkqW0oiy2ZSFQrYVPkECHNTa4naGjCIhsmirixVea5MZVa9PXGyzu18-zZw6N1iFkqez6nhdgguK9BmqDHLI3r8B31pB9_E6yIltUGrACKVranStyF4rl3nZwvyS4fgVm7d2q2Lbt2nW7eMQ0df0cNkwdXPyLfMCMg1EGKrmbL_3f1P7Aeur4Mw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2637819500</pqid></control><display><type>article</type><title>Fetal exposure to canakinumab: a report of three pregnancies</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>İlgen, Ufuk ; Eyüpoğlu, Şahin ; Yayla, Müçteba Enes ; Küçükşahin, Orhan</creator><creatorcontrib>İlgen, Ufuk ; Eyüpoğlu, Şahin ; Yayla, Müçteba Enes ; Küçükşahin, Orhan</creatorcontrib><identifier>ISSN: 0770-3198</identifier><identifier>EISSN: 1434-9949</identifier><identifier>DOI: 10.1007/s10067-022-06060-y</identifier><identifier>PMID: 35018583</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal, Humanized - adverse effects ; Double-Blind Method ; Female ; Fetuses ; Humans ; Interleukin-1beta ; Letters of Biomedical and Clinical Research ; Medicine ; Medicine &amp; Public Health ; Pregnancy ; Rheumatology ; Treatment Outcome</subject><ispartof>Clinical rheumatology, 2022-04, Vol.41 (4), p.1261-1263</ispartof><rights>International League of Associations for Rheumatology (ILAR) 2022</rights><rights>International League of Associations for Rheumatology (ILAR) 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-5f561aaa3c59c3aa9e8bd650e8d4b0a148f73179808118ea917d9ad4458d88f73</citedby><cites>FETCH-LOGICAL-c375t-5f561aaa3c59c3aa9e8bd650e8d4b0a148f73179808118ea917d9ad4458d88f73</cites><orcidid>0000-0002-5998-6703 ; 0000-0002-4109-0642 ; 0000-0002-8009-6262 ; 0000-0001-6443-6426</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10067-022-06060-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10067-022-06060-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35018583$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>İlgen, Ufuk</creatorcontrib><creatorcontrib>Eyüpoğlu, Şahin</creatorcontrib><creatorcontrib>Yayla, Müçteba Enes</creatorcontrib><creatorcontrib>Küçükşahin, Orhan</creatorcontrib><title>Fetal exposure to canakinumab: a report of three pregnancies</title><title>Clinical rheumatology</title><addtitle>Clin Rheumatol</addtitle><addtitle>Clin Rheumatol</addtitle><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal, Humanized - adverse effects</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Fetuses</subject><subject>Humans</subject><subject>Interleukin-1beta</subject><subject>Letters of Biomedical and Clinical Research</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Pregnancy</subject><subject>Rheumatology</subject><subject>Treatment Outcome</subject><issn>0770-3198</issn><issn>1434-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kE1LxDAQhoMoun78AQ9S8OKlOtM0TSJeRFwVBC96DrPtdF3dbWvSgvvvzbp-gAcJTA7zzDvDI8QhwikC6LMQa6FTyLIUivjS5YYYYS7z1NrcbooRaA2pRGt2xG4ILwCQGYvbYkcqQKOMHImLMfc0T_i9a8PgOenbpKSGXmfNsKDJeUKJ5671fdLWSf_smZPO87Shppxx2BdbNc0DH3z9e-JpfP14dZveP9zcXV3ep6XUqk9VrQokIlkqW0oiy2ZSFQrYVPkECHNTa4naGjCIhsmirixVea5MZVa9PXGyzu18-zZw6N1iFkqez6nhdgguK9BmqDHLI3r8B31pB9_E6yIltUGrACKVranStyF4rl3nZwvyS4fgVm7d2q2Lbt2nW7eMQ0df0cNkwdXPyLfMCMg1EGKrmbL_3f1P7Aeur4Mw</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>İlgen, Ufuk</creator><creator>Eyüpoğlu, Şahin</creator><creator>Yayla, Müçteba Enes</creator><creator>Küçükşahin, Orhan</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5998-6703</orcidid><orcidid>https://orcid.org/0000-0002-4109-0642</orcidid><orcidid>https://orcid.org/0000-0002-8009-6262</orcidid><orcidid>https://orcid.org/0000-0001-6443-6426</orcidid></search><sort><creationdate>20220401</creationdate><title>Fetal exposure to canakinumab: a report of three pregnancies</title><author>İlgen, Ufuk ; Eyüpoğlu, Şahin ; Yayla, Müçteba Enes ; Küçükşahin, Orhan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-5f561aaa3c59c3aa9e8bd650e8d4b0a148f73179808118ea917d9ad4458d88f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal, Humanized - adverse effects</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Fetuses</topic><topic>Humans</topic><topic>Interleukin-1beta</topic><topic>Letters of Biomedical and Clinical Research</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Pregnancy</topic><topic>Rheumatology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>İlgen, Ufuk</creatorcontrib><creatorcontrib>Eyüpoğlu, Şahin</creatorcontrib><creatorcontrib>Yayla, Müçteba Enes</creatorcontrib><creatorcontrib>Küçükşahin, Orhan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>İlgen, Ufuk</au><au>Eyüpoğlu, Şahin</au><au>Yayla, Müçteba Enes</au><au>Küçükşahin, Orhan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fetal exposure to canakinumab: a report of three pregnancies</atitle><jtitle>Clinical rheumatology</jtitle><stitle>Clin Rheumatol</stitle><addtitle>Clin Rheumatol</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>41</volume><issue>4</issue><spage>1261</spage><epage>1263</epage><pages>1261-1263</pages><issn>0770-3198</issn><eissn>1434-9949</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>35018583</pmid><doi>10.1007/s10067-022-06060-y</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-5998-6703</orcidid><orcidid>https://orcid.org/0000-0002-4109-0642</orcidid><orcidid>https://orcid.org/0000-0002-8009-6262</orcidid><orcidid>https://orcid.org/0000-0001-6443-6426</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0770-3198
ispartof Clinical rheumatology, 2022-04, Vol.41 (4), p.1261-1263
issn 0770-3198
1434-9949
language eng
recordid cdi_proquest_miscellaneous_2619217124
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Humanized - adverse effects
Double-Blind Method
Female
Fetuses
Humans
Interleukin-1beta
Letters of Biomedical and Clinical Research
Medicine
Medicine & Public Health
Pregnancy
Rheumatology
Treatment Outcome
title Fetal exposure to canakinumab: a report of three pregnancies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T18%3A09%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fetal%20exposure%20to%20canakinumab:%20a%20report%20of%20three%20pregnancies&rft.jtitle=Clinical%20rheumatology&rft.au=%C4%B0lgen,%20Ufuk&rft.date=2022-04-01&rft.volume=41&rft.issue=4&rft.spage=1261&rft.epage=1263&rft.pages=1261-1263&rft.issn=0770-3198&rft.eissn=1434-9949&rft_id=info:doi/10.1007/s10067-022-06060-y&rft_dat=%3Cproquest_cross%3E2619217124%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2637819500&rft_id=info:pmid/35018583&rfr_iscdi=true